Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.
2.
4.

Immunohistochemical study of angiotensin receptors in human anagen hair follicles and basal cell carcinoma.

Takeda H, Katagata Y, Kondo S.

Br J Dermatol. 2002 Aug;147(2):276-80.

PMID:
12174099
5.

Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.

Batinac T, Zamolo G, Coklo M, Hadzisejdic I, Stemberger C, Zauhar G.

Pathol Res Pract. 2006;202(8):599-607. Epub 2006 Jun 15.

PMID:
16781827
6.
7.

Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.

Batinac T, Zamolo G, Brumini G, Biljan D, Petranović D, Troselj-Vukić B.

Coll Antropol. 2008 Jun;32(2):499-504.

PMID:
18756900
8.
10.

The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.

Fujii M, Honma M, Takahashi H, Ishida-Yamamoto A, Iizuka H.

Clin Exp Dermatol. 2011 Oct;36(7):788-92. doi: 10.1111/j.1365-2230.2011.04118.x. Epub 2011 Aug 25.

PMID:
21883393
11.
12.
13.
14.

The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.

Sakiz D, Turkmenoglu TT, Kabukcuoglu F.

Pathol Res Pract. 2009;205(9):589-94. doi: 10.1016/j.prp.2009.01.010. Epub 2009 Jul 5.

PMID:
19577853
15.

p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.

Kaabipour E, Haupt HM, Stern JB, Kanetsky PA, Podolski VF, Martin AM.

Arch Pathol Lab Med. 2006 Jan;130(1):69-73.

PMID:
16390241
16.

IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.

Soddu S, Di Felice E, Cabras S, Castellanos ME, Atzori L, Faa G, Pilloni L.

Eur J Histochem. 2013 Feb 14;57(1):e6. doi: 10.4081/ejh.2013.e6.

17.

Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.

Park HR, Min SK, Min K, Jun SY, Seo J, Kim KH, Choi J.

Int J Dermatol. 2010 Jan;49(1):48-52. doi: 10.1111/j.1365-4632.2009.04191.x.

PMID:
20465611
18.

Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.

Tan KB, Lee YS.

Histopathology. 2009 Sep;55(3):338-45. doi: 10.1111/j.1365-2559.2009.03375.x.

PMID:
19723149
19.

Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.

Kanzaki A, Kudo M, Ansai S, Peng WX, Ishino K, Yamamoto T, Wada R, Fujii T, Teduka K, Kawahara K, Kawamoto Y, Kitamura T, Kawana S, Saeki H, Naito Z.

Int J Oncol. 2016 Mar;48(3):1007-15. doi: 10.3892/ijo.2016.3323. Epub 2016 Jan 5.

Supplemental Content

Support Center